Updated:
Cantheon Capital
Cantheon Capital provides corporate advisory, capital funding, and scientific advice to cannabinoid and psychedelic biotechs. The firm focuses on early and...
Cantheon Capital
Cantheon Capital provides corporate advisory, capital funding, and scientific advice to cannabinoid and psychedelic biotechs. The firm focuses on early and mid-stage companies navigating clinical trials. It is based in Singapore.
General information
Firm type
Private Equity
Location
Region
North America
Country
United States
City
Dallas
Corporate office
Dallas, TX, United States
Frequently asked questions
Who are the key investment decision-makers at Cantheon Capital?
The principals and investment committee members of Cantheon Capital are not publicly identified. The firm's website and available public records do not list the names, titles, or professional backgrounds of any managing partners, principals, or deal leads.
How large is Cantheon Capital in terms of assets under management?
Cantheon Capital does not publicly disclose its assets under management. No regulatory filings or credible media reports have published an AUM figure for the firm. Without such a source, the firm's scale of operations remains private.
Does Cantheon Capital disclose any named portfolio companies?
No portfolio company names are publicly listed by Cantheon Capital. A review of the firm's website and professional network profiles reveals no disclosed investments, making it impossible to characterize the firm's track record or specific sector expertise from public data.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: